Levemir FDA Approval History
Levemir (insulin detemir) is a novel, long- acting form of insulin that provides up to a 24-hour duration of action for the treatment of diabetes mellitus (type 1 and type 2).
Development timeline for Levemir
|May 22, 2012||Approval FDA Approves Levemir for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes|
|Apr 2, 2012||Approval FDA Approves Levemir Pregnancy Category Change for Women with Diabetes|
|Jun 16, 2005||Approval Levemir Novo Nordisk Inc. - Treatment for Diabetes Mellitus (Type 1 and Type 2)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.